Our Sole Focus: Human Therapeutic Antibody Discovery

We understand how to position your discovery program for success while navigating through potential pitfalls, because we have years of experience in generation of therapeutic-quality antibodies from rodents, both wild-type and transgenic.

We work with companies large and small, ranging from companies operating virtually to established companies wanting to enhance their existing capabilities.

Our team of experts will become your team of experts, creating a tailored therapeutic discovery project.


Jonah Rainey, PhD

Jonah Rainey, PhD >

VP of Antibody Engineering and Protein Science

Board of Directors

Larry Green, PhD

Larry Green, PhD >

Executive Chairman

Meet Our Team

James Graziano, PhD

James Graziano, PhD >

Senior Director, Operations

Dana Duey

Dana Duey >

Director, Antibody Discovery

Jacek Ostrowski, PhD

Jacek Ostrowski, PhD >

Associate Director, Protein Chemistry

Ritsuko Sawada, PhD

Ritsuko Sawada, PhD >

Senior Scientist II

Crystal Bantados, PMP

Crystal Bantados, PMP >

Senior Manager, Discovery Operations and Project Management

Stacey Borders

Stacey Borders >

Market Development Partner

Travis Grant

Travis Grant >

Research Associate I

Ali Ataei

Ali Ataei >

Senior Research Associate I

Blisseth Sy, MS

Blisseth Sy, MS >

Director, Business Development

Tracy Charlton, PhD

Tracy Charlton, PhD >

Associate Director, Antibody Discovery

Alex Reiss, MS

Alex Reiss, MS >

Manager, Discovery Operations

Mary Dwyer, PhD

Mary Dwyer, PhD >

Associate Director, Antibody Discovery

Hayden Knutson

Hayden Knutson >

Intern, Protein Sciences

Oscar Martinez

Oscar Martinez >

Research Associate I

Angel Payan, MS

Angel Payan, MS >

Research Associate II

Ezechinyere Ukabiala

Ezechinyere Ukabiala >

Research Associate I

Soneela Ramesh, PhD

Soneela Ramesh, PhD >

Senior Project Manager

Our Relationship with Ablexis

We use the AlivaMab Mouse, developed by Ablexis, LLC, as the platform for your discovery project. Chosen by many leading pharmaceutical companies, this best-in-class transgenic platform generates human therapeutic antibody candidates with high potency, specificity, developability qualities and reduced chances of immunogenicity.

We founded AlivaMab Discovery Services after hearing the needs of many prospective partners wanting to outsource discovery to a scientifically-driven organization led by a team with in-the-trenches experience and real understanding of therapeutic antibody discovery and development.

To learn more visit www.ablexis.com

AllivaMab Mouse